Eli Lilly : LLY

All Eli Lilly Articles

668 Articles

Omor Ibne Ehsan | May 27, 2026 at 3:45 PM EDT

Buy, Sell, or Hold Vanguard’s Mega Cap Growth ETF Right Now | MGK

There’s a tech ETF that has been almost neck-and-neck with the S&P 500 in the past year and has built…

Trey Thoelcke | May 26, 2026 at 8:50 AM EDT

If Viking Therapeutics Is Acquired, Here’s Who Wins

Polymarket traders are watching one biotech more closely than any other for an acquisition. Viking Therapeutics (NASDAQ: VKTX | VKTX…

Michael Williams | May 25, 2026 at 9:30 AM EDT

VIG Investors: Watch the 10-Year Treasury Yield This Week—4.75% Is the Danger Line

The Vanguard Dividend Appreciation Index Fund ETF Shares (NYSEARCA:VIG) is having a quieter year than its big-cap dividend-growth reputation suggests,…

Trey Thoelcke | May 21, 2026 at 9:05 AM EDT

Will ASML, Lilly, or TransDigm Be the Next Big Stock Split?

Wall Street has rediscovered the stock-split playbook. KLA (NASDAQ: KLAC | KLAC Price Prediction) announced a 10-for-1 forward stock split in…

Vandita Jadeja | May 21, 2026 at 8:25 AM EDT

Can Eli Lilly Stock Reach $1800 by 2030? Here Is the Bull Case

Eli Lilly (NYSE:LLY | LLY Price Prediction) is growing like a software company. Q1 2026 revenue hit $19.80B, up 55.5%…

Don Lair | May 20, 2026 at 1:22 AM EDT

“4,000% or 5,000% Over Five or Six Years”: Why Patient Investors in NVDA, AMD, and LLY Are Winning

On a recent episode of Earn Your Leisure titled “The #1 Investing Mistake Keeping You Broke,” co-host E delivered a…

Omor Ibne Ehsan | May 19, 2026 at 4:19 PM EDT

Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?

The iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) is the rare fund that has spent the past year being publicly threatened by…

Omor Ibne Ehsan | May 19, 2026 at 11:12 AM EDT

If You Hold This Healthcare ETF, You’re Losing Big

The Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) is down about 5% year to date while the S&P 500 is…

Alex Sirois | May 18, 2026 at 1:55 PM EDT

Three Biotechs That Are Top Takeover Targets

Eli Lilly (NYSE:LLY | LLY Price Prediction) is the stock everyone wants to talk about, and the reasons are obvious:…

Thomas Richmond | May 15, 2026 at 10:35 AM EDT

Prediction. The S&P 500 Is So Far Above Its Moving Averages That a 10% Correction This Summer Is Not Out of the Question

Lance Roberts of RIA Advisors warned on the Thoughtful Money podcast that the S&P 500 has stretched so far above…

Vandita Jadeja | May 14, 2026 at 1:34 PM EDT

Is Eli Lilly Going To $1,100?

Eli Lilly (NYSE:LLY | LLY Price Prediction) just delivered one of the most impressive quarters in big pharma history, and…

Vandita Jadeja | May 12, 2026 at 11:25 AM EDT

Eli Lilly Price Prediction: This Is Where The Stock Will End This Year

Few stocks have polarized investors in 2026 like Eli Lilly (NYSE:LLY | LLY Price Prediction). After a stunning Q1 earnings…

Trey Thoelcke | May 12, 2026 at 7:40 AM EDT

Lilly Bounces Into ‘Sell in May’ Territory as Pricing Pressures Loom

The market adage “Sell in May and Go Away” rarely fits a single name cleanly. Eli Lilly (NYSE: LLY |…

Trey Thoelcke | May 11, 2026 at 9:05 AM EDT

Pfizer vs Eli Lilly: Different Bets on Pharma M&A

Pfizer (NYSE: PFE | PFE Price Prediction) and Eli Lilly (NYSE: LLY) recently reported quarterly results that read like two…

Vandita Jadeja | May 6, 2026 at 10:46 AM EDT

If You Want to Beat the Market, Start With These 3 Stocks

Investors are concerned about where the stock market is headed this year. While the S&P 500 has maintained upward momentum,…

1 2 3 4 5 … 45

Eli Lilly : LLY

All Eli Lilly Articles

Buy, Sell, or Hold Vanguard’s Mega Cap Growth ETF Right Now | MGK

If Viking Therapeutics Is Acquired, Here’s Who Wins

VIG Investors: Watch the 10-Year Treasury Yield This Week—4.75% Is the Danger Line

Will ASML, Lilly, or TransDigm Be the Next Big Stock Split?

Can Eli Lilly Stock Reach $1800 by 2030? Here Is the Bull Case

“4,000% or 5,000% Over Five or Six Years”: Why Patient Investors in NVDA, AMD, and LLY Are Winning

Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?

If You Hold This Healthcare ETF, You’re Losing Big

Three Biotechs That Are Top Takeover Targets

Prediction. The S&P 500 Is So Far Above Its Moving Averages That a 10% Correction This Summer Is Not Out of the Question

Is Eli Lilly Going To $1,100?

Eli Lilly Price Prediction: This Is Where The Stock Will End This Year

Lilly Bounces Into ‘Sell in May’ Territory as Pricing Pressures Loom

Pfizer vs Eli Lilly: Different Bets on Pharma M&A

If You Want to Beat the Market, Start With These 3 Stocks

“Grow a Spine”: All-In Podcast Pushes Back on AI Regulation and Calls PayPal’s $60 Takeover Offer Just an Opening Bid

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

$3,000 a Month in Sun City: Here’s How to Retire There at 62 Without Touching Your Savings

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

$3,000 a Month in Sun City: Here's How to Retire There at 62 Without Touching Your Savings

“Grow a Spine”: All-In Podcast Pushes Back on AI Regulation and Calls PayPal’s $60 Takeover Offer Just an Opening Bid

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

Eli Lilly : LLY

All Eli Lilly Articles

Buy, Sell, or Hold Vanguard’s Mega Cap Growth ETF Right Now | MGK

If Viking Therapeutics Is Acquired, Here’s Who Wins

VIG Investors: Watch the 10-Year Treasury Yield This Week—4.75% Is the Danger Line

Will ASML, Lilly, or TransDigm Be the Next Big Stock Split?

Can Eli Lilly Stock Reach $1800 by 2030? Here Is the Bull Case

“4,000% or 5,000% Over Five or Six Years”: Why Patient Investors in NVDA, AMD, and LLY Are Winning

Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?

If You Hold This Healthcare ETF, You’re Losing Big

Three Biotechs That Are Top Takeover Targets

Prediction. The S&P 500 Is So Far Above Its Moving Averages That a 10% Correction This Summer Is Not Out of the Question

Is Eli Lilly Going To $1,100?

Eli Lilly Price Prediction: This Is Where The Stock Will End This Year

Lilly Bounces Into ‘Sell in May’ Territory as Pricing Pressures Loom

Pfizer vs Eli Lilly: Different Bets on Pharma M&A

If You Want to Beat the Market, Start With These 3 Stocks

“Grow a Spine”: All-In Podcast Pushes Back on AI Regulation and Calls PayPal’s $60 Takeover Offer Just an Opening Bid

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

$3,000 a Month in Sun City: Here’s How to Retire There at 62 Without Touching Your Savings

Featured Reads

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

$3,000 a Month in Sun City: Here's How to Retire There at 62 Without Touching Your Savings